Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recombinant adeno-associated virus type 2 (AAV2) vectors have shown great promise in current ophthalmology clinical trials targeting gene delivery to the retinal pigment epithelium (RPE). To treat the majority of retinal diseases, however, gene delivery would need to be targeted to photoreceptor neurons of the outer retina. AAV2 pseudotyped with the AAV5 capsid (AAV2/5) has shown far greater transduction efficiency in photoreceptors compared to standard AAV2 vectors. For clinical trial applications using gene therapy, it is helpful to generate pre-clinical data in human cells wherever possible. There is however very little data, indeed some controversy, as to whether AAV2/5 can be used effectively in differentiated neurons in culture. In this study we show that transduction of the human neuroblastoma cell line SH-SY5Y with recombinant AAV2/5 expressing GFP is well tolerated. Furthermore, we explore the mechanism whereby exposure to retinoic acid (RA) and the phorbol ester 12-O-Tetradecanoylphorbol-13- acetate (TPA) can induce this cell line to differentiate into a stable population of human neurons, with significantly increased levels of AAV2/5 transduction. These observations may be helpful for assessing AAV2/5 vectors in vitro, particularly where it is necessary to generate pre-clinical data for clinical trials of gene therapy to the human central nervous system.

Original publication

DOI

10.1016/j.exer.2011.12.009

Type

Journal article

Journal

Exp Eye Res

Publication Date

04/2012

Volume

97

Pages

148 - 153

Keywords

Ataxia Telangiectasia Mutated Proteins, Carcinogens, Cell Cycle Proteins, Cell Differentiation, Cell Division, DNA-Binding Proteins, Dependovirus, Gene Expression Regulation, Genetic Vectors, Green Fluorescent Proteins, HEK293 Cells, Humans, Protein-Serine-Threonine Kinases, RNA, Messenger, Real-Time Polymerase Chain Reaction, Receptors, Platelet-Derived Growth Factor, Retinal Neoplasms, Retinoblastoma, Tacrolimus Binding Proteins, Tetradecanoylphorbol Acetate, Transduction, Genetic, Tretinoin, Tumor Cells, Cultured, Tumor Suppressor Proteins